| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| [2] |
Culp MB, Soerjomataram I, Efstathiou JA, et al. Recent global patterns in prostate cancer incidence and mortality rates [J]. Eur Urol, 2020, 77(1): 38-52.
|
| [3] |
HA Chung B, Horie S, Chiong E. The incidence, mortality, and risk factors of prostate cancer in Asian men [J]. Prostate Int, 2019, 7(1): 1-8.
|
| [4] |
Bill-Axelson A, Holmberg L, Garmo H, et al. Radical prostatectomy or watchful waiting in prostate cancer - 29-year follow-up [J]. N Engl J Med, 2018, 379(24): 2319-2329.
|
| [5] |
Wallis CJD, Glaser A, Hu JC, et al. Survival and complications following surgery and radiation for localized prostate cancer: an international collaborative review [J]. Eur Urol, 2018, 73(1): 11-20.
|
| [6] |
Corpet A, De Koning L, Toedling J, et al. Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer [J]. EMBO J, 2011, 30(3): 480-493.
|
| [7] |
Liu X, Song J, Zhang Y, et al. ASF1B promotes cervical cancer progression through stabilization of CDK9 [J]. Cell Death Dis, 2020, 11(8): 705.
|
| [8] |
Ma J, Han W, Lu K. Comprehensive pan-cancer analysis and the regulatory mechanism of asf1b, a gene associated with thyroid cancer prognosis in the tumor micro-environment[J]. Front Oncol, 2021, 11：711756.
|
| [9] |
Zhou JQ, Qiu T, Chen ZB, et al. Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma[J]. Biochem Biophys Res Commun, 2019, 511(1): 165-172.
|
| [10] |
Carrion A, Ingelmo-torres M, Lozano JJ, et al. Prognostic classifier for predicting biochemical recurrence in localized prostate cancer patients after radical prostatectomy[J]. Urol Oncol, 2021, 39(8): 493 e17-e25.
|
| [11] |
Hattori N, Ushijima T. Compendium of aberrant DNA methylation and histone modifications in cancer [J]. Biochem Biophys Res Commun, 2014, 455(1-2): 3-9.
|
| [12] |
Gurard-levin ZA, Almouzni G. Histone modifications and a choice of variant: a language that helps the genome express itself [J]. F1000Prime Rep, 2014, 6: 76.
|
| [13] |
Segura-bayona S, Stracker TH. The Tousled-like kinases regulate genome and epigenome stability: implications in development and disease [J]. Cell Mol Life Sci, 2019, 76(19): 3827-3841.
|
| [14] |
Huang J. Current developments of targeting the p53 signaling pathway for cancer treatment [J]. Pharmacol Ther, 2021, 220: 107720.
|
| [15] |
Xiao BD, Zhao YJ, Jia XY, et al. Multifaceted p21 in carcinogenesis, stemness of tumor and tumor therapy [J]. World J Stem Cells, 2020, 12(6): 481-7.
|
| [16] |
Taylor WR, Stark GR. Regulation of the G2/M transition by p53 [J]. Oncogene, 2001, 20(15): 1803-1815.
|
| [17] |
Li M, Wu W, Deng S, et al. TRAIP modulates the IGFBP3/AKT pathway to enhance the invasion and proliferation of osteosarcoma by promoting KANK1 degradation [J]. Cell Death Dis, 2021, 12(8): 767.
|
| [18] |
Park J, Jung MJ, Chung WY. The downregulation of IGFBP3 by TGF-beta signaling in oral cancer contributes to the osteoclast differentiation[J]. Biochem Biophys Res Commun, 2021, 534:381-386.
|
| [19] |
Shan Z, Liu Q, Li Y, et al. PUMA decreases the growth of prostate cancer PC-3 cells independent of p53 [J]. Oncol Lett, 2017, 13(3): 1885-1890.
|
| [20] |
Dey P, Strom A, Gustafsson JA. Estrogen receptor beta upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer [J]. Oncogene, 2014, 33(33): 4213-4225.
|
| [21] |
Wang SP, Wang WL, Chang YL, et al. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug [J]. Nat Cell Biol, 2009, 11(6): 694-704.
|
| [22] |
Zhang J, Lei Y, Gao X, et al. p53 Attenuates the oncogenic Ras-induced epithelial-mesenchymal transition in human mammary epithelial cells [J]. Biochem Biophys Res Commun, 2013, 434(3): 606-613.
|
| [23] |
Wang Z, Jiang Y, Guan D, et al. Critical roles of p53 in epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma cells [J]. PLoS One, 2013, 8(9): e72846.
|
| [24] |
Boutelle AM, Attardi LD. p53 and tumor suppression: it takes a network [J]. Trends Cell Biol, 2021, 31(4): 298-310.
|
| [25] |
Marei HE, Althani A, Afifi N, et al. p53 signaling in cancer progression and therapy [J]. Cancer Cell Int, 2021, 21(1): 703.
|
| [26] |
蔡江怡，朱乐乐. 组蛋白伴侣ASF1B在前列腺癌细胞的表达及其对体外细胞活力的影响[J]. 中国病理生理杂志, 2020, 36(9): 1602-1607.
|
| [27] |
Han G, Zhang X, Liu P, et al. Knockdown of anti-silencing function 1B histone chaperone induces cell apoptosis via repressing PI3K/Akt pathway in prostate cancer [J]. Int J Oncol, 2018, 53(5): 2056-2066.
|